A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
Journal
BMC Cancer
Journal Volume
17
Journal Issue
1
Pages
646
Date Issued
2017
Author(s)
Reynolds K.L.
Bedard P.L.
Lee S.-H.
Tabernero J.
Alsina M.
Cohen E.
Baselga J.
Blumenschein G.
Graham D.M.
Garrido-Laguna I.
Juric D.
Sharma S.
Salgia R.
Seroutou A.
Tian X.
Fernandez R.
Morozov A.
Sheng Q.
Ramkumar T.
Zubel A.
Bang Y.-J.
SDGs
Publisher
BioMed Central Ltd.
Type
journal article